New Model for Spying on Prostate Cancer and Bone Dynamics Developed

by Colleen Fleiss on  August 3, 2018 at 8:01 AM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

MD Anderson researchers have engineered a system that allows microscopic monitoring and imaging of cancer that has spread to the bone in mice. The new method helps scientists to better understand and develop treatment for bone metastasis in humans.
New Model for Spying on Prostate Cancer and Bone Dynamics Developed
New Model for Spying on Prostate Cancer and Bone Dynamics Developed

"Advanced prostate cancer and other cancers metastasize to the bones, causing resistance to therapy and pain for patients, but it's not really clear what makes the bone so special to prostate cancer progression," said Eleonora Dondossola, Ph.D., instructor in Genitourinary Medical Oncology and lead author of a paper in Science Translational Medicine.

"Bone probably provides cues and an attractive microenvironment for cancer cells to grow," she notes, but noninvasive microscopy to study the process in detail is hindered by the thickness of the outer bone blocking the view of inner cavity and bone marrow.

"It was a black box. Finally, our model allows us to get inside the bone with intravital multiphoton microscopy and shed some light on these phenomena," she said.

The researchers show how the technique can monitor and capture the dynamics of tumor cell interaction with bone and bone resident cells as they occur over time.

A tissue-engineered construct under a mouse's skin develops in about a month into bone with an internal cavity and a thin outer layer that the microscope can "see" through.

After bone marrow and other cells populate the cavity, a cancer cell line is injected.

Multiphoton microscopy is a fluorescent imaging technique used to image living tissue. The microscopes in the lab of Peter Friedl, M.D., Ph.D., professor of Genitourinary Medical Oncology, can capture up to seven parameters at a time. Friedl is senior author of the study.

The bone construct was developed by a team of scientists at the Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology, in Brisbane, Australia, led by Dietmar Hutmacher, Ph.D.

Normal bone biology involves a balance between bone-creating cells called osteoblasts, and bone-destroying cells called osteoclasts, Dondossola notes. Cancer tips this balance, altering the equilibrium between these two populations and leading to symptomatic bone remodeling.

The team's microscopy showed bone loss concentrated around osteoclasts near the tumor. This phenomenon is a known and painful issue for patients with prostate cancer bone metastasis, and a class of drugs called bisphosphonates is used to relieve this symptom. In the clinic, the effect is known to be palliative, relieving pain but not prolonging survival.

The team's multiphoton microscopy captured this effect. They treated the mice with the bisphosphonate zoledronic acid and found that the drug did not reduce the number of osteoclasts, but slowed their activity, preserving bone. Notably, the treatment had no effect on tumor growth, and this explains why the bone is stabilized but patient survival is not prolonged.

Friedl's lab is using this model to study cancer treatments in mice, including co-clinical work in immunotherapy and radiation. Drugs that free the immune system to attack cancer are often thwarted by resistance factors in the tumor microenvironment, which the team hopes to observe and characterize.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Infantile Cortical Hyperostosis Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Tattoos A Body Art Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive